 Aaron Knox
Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Keratin-5 | 1 | 2014 | 47 | 0.490 |
Why?
| | Receptors, Progesterone | 1 | 2014 | 325 | 0.430 |
Why?
| | Receptors, Estrogen | 1 | 2014 | 387 | 0.410 |
Why?
| | Pituitary Neoplasms | 5 | 2015 | 165 | 0.380 |
Why?
| | Phosphoribosylglycinamide Formyltransferase | 1 | 2008 | 1 | 0.340 |
Why?
| | Purines | 1 | 2008 | 161 | 0.310 |
Why?
| | Models, Biological | 1 | 2014 | 1715 | 0.290 |
Why?
| | Gonadotrophs | 4 | 2015 | 21 | 0.260 |
Why?
| | Breast Neoplasms | 1 | 2014 | 1965 | 0.220 |
Why?
| | raf Kinases | 1 | 2021 | 12 | 0.210 |
Why?
| | MAP Kinase Signaling System | 1 | 2021 | 292 | 0.180 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2021 | 181 | 0.180 |
Why?
| | Pituitary Gland | 3 | 2015 | 163 | 0.170 |
Why?
| | Adenoma | 2 | 2011 | 191 | 0.160 |
Why?
| | Glioma | 1 | 2021 | 306 | 0.160 |
Why?
| | Mutation | 1 | 2008 | 3457 | 0.160 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 42 | 0.130 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2015 | 1167 | 0.120 |
Why?
| | MCF-7 Cells | 1 | 2014 | 111 | 0.120 |
Why?
| | Heterografts | 1 | 2014 | 130 | 0.120 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2014 | 175 | 0.120 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2014 | 189 | 0.120 |
Why?
| | Small Molecule Libraries | 1 | 2014 | 80 | 0.120 |
Why?
| | Immunophenotyping | 1 | 2014 | 278 | 0.120 |
Why?
| | Brain Neoplasms | 1 | 2021 | 1022 | 0.120 |
Why?
| | Prolactinoma | 1 | 2011 | 11 | 0.100 |
Why?
| | Antigens, Differentiation | 1 | 2011 | 79 | 0.100 |
Why?
| | Cell Proliferation | 4 | 2015 | 2275 | 0.100 |
Why?
| | Ki-67 Antigen | 1 | 2011 | 108 | 0.100 |
Why?
| | ErbB Receptors | 1 | 2014 | 569 | 0.100 |
Why?
| | Glycoproteins | 1 | 2012 | 319 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 4 | 2015 | 770 | 0.090 |
Why?
| | Gene Expression Profiling | 2 | 2014 | 1597 | 0.090 |
Why?
| | Cell Line, Tumor | 2 | 2014 | 2851 | 0.090 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 289 | 0.090 |
Why?
| | Endothelial Cells | 1 | 2014 | 732 | 0.080 |
Why?
| | Blotting, Northern | 1 | 2008 | 194 | 0.080 |
Why?
| | Cricetulus | 1 | 2008 | 98 | 0.080 |
Why?
| | CHO Cells | 1 | 2008 | 143 | 0.080 |
Why?
| | Biocatalysis | 1 | 2008 | 64 | 0.080 |
Why?
| | Cricetinae | 1 | 2008 | 262 | 0.080 |
Why?
| | DNA, Complementary | 1 | 2008 | 268 | 0.080 |
Why?
| | Cell Cycle Proteins | 1 | 2012 | 565 | 0.080 |
Why?
| | Gene Dosage | 1 | 2008 | 136 | 0.080 |
Why?
| | Cloning, Molecular | 1 | 2008 | 546 | 0.080 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2011 | 455 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 2014 | 1346 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2008 | 290 | 0.080 |
Why?
| | Animals | 7 | 2014 | 33381 | 0.070 |
Why?
| | Transfection | 1 | 2008 | 888 | 0.070 |
Why?
| | Genome | 1 | 2008 | 277 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2008 | 404 | 0.070 |
Why?
| | Cystathionine beta-Synthase | 1 | 2006 | 60 | 0.070 |
Why?
| | Blotting, Western | 1 | 2008 | 1194 | 0.070 |
Why?
| | Mice | 5 | 2014 | 15520 | 0.070 |
Why?
| | Sequence Analysis, DNA | 1 | 2008 | 755 | 0.070 |
Why?
| | Up-Regulation | 3 | 2015 | 872 | 0.070 |
Why?
| | RNA, Messenger | 2 | 2011 | 2657 | 0.060 |
Why?
| | Disease Models, Animal | 1 | 2014 | 3730 | 0.060 |
Why?
| | Cell Survival | 3 | 2015 | 1047 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 982 | 0.060 |
Why?
| | Biomarkers | 1 | 2014 | 3588 | 0.060 |
Why?
| | Molecular Sequence Data | 1 | 2008 | 2871 | 0.060 |
Why?
| | Down Syndrome | 1 | 2006 | 356 | 0.050 |
Why?
| | Mice, Transgenic | 1 | 2006 | 2025 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 2014 | 1691 | 0.040 |
Why?
| | Humans | 9 | 2021 | 118974 | 0.040 |
Why?
| | Female | 4 | 2021 | 61565 | 0.040 |
Why?
| | Cell Line | 2 | 2012 | 2707 | 0.030 |
Why?
| | Tumor Stem Cell Assay | 1 | 2015 | 35 | 0.030 |
Why?
| | Cytoprotection | 1 | 2015 | 55 | 0.030 |
Why?
| | Gene Amplification | 1 | 2015 | 97 | 0.030 |
Why?
| | E-Selectin | 1 | 2014 | 52 | 0.030 |
Why?
| | Mutant Proteins | 1 | 2015 | 100 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 2014 | 91 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2015 | 220 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2015 | 167 | 0.030 |
Why?
| | Immunoblotting | 1 | 2014 | 307 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 285 | 0.030 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 246 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2014 | 443 | 0.030 |
Why?
| | Microscopy, Fluorescence | 1 | 2014 | 412 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 420 | 0.030 |
Why?
| | RNA Interference | 1 | 2014 | 460 | 0.030 |
Why?
| | G2 Phase | 1 | 2012 | 33 | 0.030 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 823 | 0.030 |
Why?
| | Genes, Tumor Suppressor | 1 | 2012 | 77 | 0.030 |
Why?
| | CpG Islands | 1 | 2012 | 119 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2014 | 576 | 0.030 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2012 | 113 | 0.030 |
Why?
| | Cavernous Sinus | 1 | 2011 | 16 | 0.030 |
Why?
| | Mitotic Index | 1 | 2011 | 27 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2015 | 415 | 0.030 |
Why?
| | Skull Base | 1 | 2011 | 44 | 0.030 |
Why?
| | Cytoplasm | 1 | 2012 | 269 | 0.020 |
Why?
| | Genes, p53 | 1 | 2011 | 64 | 0.020 |
Why?
| | NF-kappa B | 1 | 2014 | 670 | 0.020 |
Why?
| | Tumor Burden | 1 | 2011 | 274 | 0.020 |
Why?
| | Cell Division | 1 | 2012 | 776 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2011 | 462 | 0.020 |
Why?
| | Male | 4 | 2021 | 57801 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1171 | 0.020 |
Why?
| | Gonadotropins, Pituitary | 1 | 2008 | 22 | 0.020 |
Why?
| | Gene Expression | 1 | 2014 | 1489 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 1012 | 0.020 |
Why?
| | DNA Damage | 1 | 2011 | 357 | 0.020 |
Why?
| | Signal Transduction | 2 | 2015 | 4709 | 0.020 |
Why?
| | Radiography | 1 | 2011 | 861 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2012 | 1158 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 874 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2008 | 369 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 4077 | 0.020 |
Why?
| | Diploidy | 1 | 2006 | 12 | 0.020 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2006 | 33 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2008 | 394 | 0.020 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2011 | 900 | 0.020 |
Why?
| | Apoptosis | 1 | 2015 | 2484 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2006 | 310 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 4908 | 0.020 |
Why?
| | Inflammation | 1 | 2014 | 2566 | 0.010 |
Why?
| | Adolescent | 1 | 2021 | 18480 | 0.010 |
Why?
| | Aged | 2 | 2011 | 19657 | 0.010 |
Why?
| | Child | 1 | 2021 | 19129 | 0.010 |
Why?
| | Cognition Disorders | 1 | 2006 | 529 | 0.010 |
Why?
| | Middle Aged | 2 | 2011 | 27617 | 0.010 |
Why?
| | Time Factors | 1 | 2011 | 6412 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2011 | 6561 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2011 | 3174 | 0.010 |
Why?
| | Adult | 2 | 2011 | 31512 | 0.010 |
Why?
| | DNA | 1 | 2006 | 1388 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2011 | 9342 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2011 | 12978 | 0.010 |
Why?
|
|
Knox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|